baicalin has been researched along with Ureteral Obstruction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Wang, H; Zhang, L | 1 |
| Mao, HX; Tan, YJ; Zhu, CL | 1 |
| Hu, C; Hu, M; Li, L; Lin, M; Rong, R; Sidikejiang, N; Wang, X; Zhang, C; Zheng, L | 1 |
3 other study(ies) available for baicalin and Ureteral Obstruction
| Article | Year |
|---|---|
Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway.
Topics: Animals; Fibrosis; Flavonoids; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2022 |
[Therapeutic effect of baicalin in treatment of renal interstitial fibrosis in rats with unliateral ureteral obstruction and related mechanisms].
Topics: Animals; Fibrosis; Flavonoids; Immunohistochemistry; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptor, Notch1; Transforming Growth Factor beta1; Ureteral Obstruction | 2016 |
Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction.
Topics: Animals; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Flavonoids; Immunohistochemistry; Kidney; Kidney Diseases; Male; Models, Biological; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Ureteral Obstruction | 2017 |